A novel tylophorine analog W-8 up-regulates forkhead boxP3 expression and ameliorates murine colitis

Journal of Leukocyte Biology

Volumn 93, Issue 1, 2013, Pages 83-93

  Meng, Xianyi ^a   Zhang, Yun ^a   Jia, Zhenghu ^a   Huo, Xiaojing ^a   He, Xiangjun ^a   Tian, Gaofei ^a   Wu, Meng ^a   Wang, Ziwen ^a   Zhou, Xinglong ^a   Xiong, Sidong ^b   Gao, Xiaoming ^b   Wu, Zhenzhou ^a   Han, Jihong ^a   Zhao, Liqing ^a   Wang, Puyue ^a   Hong, Zhangyong ^a   Wang, Qingmin ^b   Yin, Zhinan ^a  

^a NANKAI UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Immune therapy; Inflammatory bowel diseases; TGF ; Treg

Indexed keywords

DNA METHYLTRANSFERASE 1; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN KINASE B; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TYLOPHORINE; UNCLASSIFIED DRUG; W 8;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; DEMETHYLATION; DRUG STRUCTURE; EPIGENETICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LYMPHOCYTE DIFFERENTIATION; LYMPHOID TISSUE; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING;

ALKALOIDS; ANIMALS; BLOTTING, WESTERN; COLITIS; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; INDOLIZINES; LYMPHOCYTE ACTIVATION; MICE; PHENANTHRENES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

MURINAE;

EID: 84871954192     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0812402     Document Type: Article

References (49)

1. Kaser, A., Zeissig, S., Blumberg, R. S. (2010) Inflammatory bowel disease. Ann. Rev. Immunol. 28, 573-6211
2. Shale, M., Ghosh, S. (2008) Beyond TNF, Th1 and Th2 in inflammatory bowel disease. Gut. 57, 1349-13511
3. Rutgeerts, P. J. (2004) An historical overview of the treatment of Crohn's disease: why do we need biological therapies? Rev. Gastroenterol. Disord. 4 (Suppl. 3), S3-S91
4. Sandborn, W. J. (2005) Inflammatory bowel disease: a new combination therapy for pouchitis. Rev. Gastroenterol. Disord. 5, 1101
5. Pizarro, T. T., Arseneau, K. O., Bamias, G., Cominelli, F. (2003) Mouse models for the study of Crohn's disease. Trends Mol. Med. 9, 218-2221
6. Strober, W., Fuss, I. J., Blumberg, R. S. (2002) The immunology of mucosal models of inflammation. Ann. Rev. Immunol. 20, 495-5491
7. Schmidt, C., Giese, T., Ludwig, B., Mueller-Molaian, I., Marth, T., Zeuzem, S., Meuer, S. C., Stallmach, A. (2005) Expression of interleukin- 12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm. Bowel Dis. 11, 16-231
8. Kitani, A., Fuss, I. J., Nakamura, K., Schwartz, O. M., Usui, T., Strober, W. (2000) Treatment of experimental (trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-β1 plasmid: TGF- β1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor β2 chain downregulation. J. Exp. Med. 192, 41-521
9. Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., Enk, A. H. (2001) Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193, 1285-12941
10. Fontenot, J. D., Gavin, M. A., Rudensky, A. Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-3361
11. Hori, S., Nomura, T., Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-10611
12. Khattri, R., Cox, T., Yasayko, S. A., Ramsdell, F. (2003) An essential role for Scurfin in CD4+CD25+T regulatory cells. Nat. Immunol. 4, 337-3421
13. Wildin, R. S., Smyk-Pearson, S., Filipovich, A. H. (2002) Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 39, 537-5451
14. Davidson, T. S., DiPaolo, R. J., Andersson, J., Shevach, E. M. (2007) Cutting edge: IL-2 is essential for TGF-β-mediated induction of Foxp3β T regulatory cells. J. Immunol. 178, 4022-40261
15. Selvaraj, R. K., Geiger, T. L. (2007) A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF- β. J. Immunol. 179, 11 p following 13901
16. Elias, K. M., Laurence, A., Davidson, T. S., Stephens, G., Kanno, Y., Shevach, E. M., O'Shea, J. J. (2008) Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111, 1013-10201
17. Sehrawat, S., Rouse, B. T. (2008) Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3β regulators. J. Immunol. 180, 7636-76471
18. You, X., Pan, M., Gao, W., Shiah, H. S., Tao, J., Zhang, D., Koumpouras, F., Wang, S., Zhao, H., Madri, J. A., Baker, D., Cheng, Y. C., Yin, Z. (2006) Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response. Arthritis Rheum. 54, 877-8861
19. Yin, Z., Zhang, D. H., Welte, T., Bahtiyar, G., Jung, S., Liu, L., Fu, X. Y., Ray, A., Craft, J. (2000) Dominance of IL-12 over IL-4 in γ δ T cell differentiation leads to default production of IFN- γ: failure to down-regulate IL-12 receptorβ2-chain expression. J. Immunol. 164, 3056-30641
20. Bai, A., Lu, N., Guo, Y., Liu, Z., Chen, J., Peng, Z. (2009) All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/ Th17 profile in human ulcerative and murine colitis. J. Leukoc. Biol. 86, 959-9691
21. Ito, R., Shin-Ya, M., Kishida, T., Urano, A., Takada, R., Sakagami, J., Imanishi, J., Kita, M., Ueda, Y., Iwakura, Y., Kataoka, K., Okanoue, T., Mazda, O. (2006) Interferon-γ is causatively involved in experimental inflammatory bowel disease in mice. Clin. Exp. Immunol. 146, 330-3381
22. Weigmann, B., Tubbe, I., Seidel, D., Nicolaev, A., Becker, C., Neurath, M. F. (2007) Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat. Protoc. 2, 2307-23111
23. Martinez, G. J., Zhang, Z., Chung, Y., Reynolds, J. M., Lin, X., Jetten, A. M., Feng, X. H., Dong, C. (2009) Smad3 differentially regulates the induction of regulatory and inflammatory T cell differentiation. J. Biol. Chem. 284, 35283-352861
24. Song, K., Wang, H., Krebs, T. L., Danielpour, D. (2006) Novel roles of Akt and mTOR in suppressing TGF-_/ALK5-mediated Smad3 activation. EMBO J. 25, 58-691
25. Song, K., Cornelius, S. C., Reiss, M., Danielpour, D. (2003) Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-I by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2. J. Biol. Chem. 278, 38342-383511
26. Chen, Y., Gorelik, G. J., Strickland, F. M., Richardson, B. C. (2010) Decreased ERK and JNK signaling contribute to gene overexpression in "senescent" CD4+CD28-T cells through epigenetic mechanisms. J. Leukoc. Biol. 87, 137-1451
27. Tang, T. T., Song, Y., Ding, Y. J., Liao, Y. H., Yu, X., Du, R., Xiao, H., Yuan, J., Zhou, Z. H., Liao, M. Y., Yao, R., Jevallee, H., Shi, G. P., Cheng, X. (2011) Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis. J. Lipid Res. 52, 1023-10321
28. Sakaguchi, S., Wing, K., Yamaguchi, T. (2009) Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur. J. Immunol. 39, 2331-23361
29. Shevach, E. M., Davidson, T. S., Huter, E. N., Dipaolo, R. A., Andersson, J. (2008) Role of TGF-β in the induction of Foxp3 expression and T regulatory cell function. J. Clin. Immunol. 28, 640-6461
30. Liston, A., Rudensky, A. Y. (2007) Thymic development and peripheral homeostasis of regulatory T cells. Curr. Opin. Immunol. 19, 176-1851
31. Kim, J. M., Rasmussen, J. P., Rudensky, A. Y. (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191-1971
32. Horwitz, D. A., Zheng, S. G., Gray, J. D. (2008) Natural and TGF-_-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol. 29, 429-4351
33. Yang, C. W., Chen, W. L., Wu, P. L., Tseng, H. Y., Lee, S. J. (2006) Antiinflammatory mechanisms of phenanthroindolizidine alkaloids. Mol. Pharmacol. 69, 749-7581
34. Yang, C. W., Lee, Y. Z., Kang, I. J., Barnard, D. L., Jan, J. T., Lin, D., Huang, C. W., Yeh, T. K., Chao, Y. S., Lee, S. J. (2010) Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus. Antiviral Res. 88, 160-1681
35. Gao, W., Lam, W., Zhong, S., Kaczmarek, C., Baker, D. C., Cheng, Y. C. (2004) Novel mode of action of tylophorine analogs as antitumor compounds. Cancer Res. 64, 678-6881
36. Wen, T., Li, Y., Wu, M., Sun, X., Bao, X., Lin, Y., Hao, J., Han, L., Cao, G., Wang, Z., Liu, Y., Wu, Z., Hong, Z., Wang, P., Zhao, L., Li, Z., Wang, Q., Yin, Z. (2012) Therapeutic effects of a novel tylophorine analog NK- 007 on collagen-induced arthritis through suppressing TNF-_ production and Th17 differentiation. Arthritis Rheum. 64, 2896-29061
37. Wen, T., Li, Y., Wu, M., Chen, X., Han, L., Bao, X., Wang, Z., Wang, K., Hu, Y., Zhou, X., Wu, Z., Wang, P., Hong, Z., Zhao, L., Wang, Q., Yin, Z. (2012) A novel tylophorine analog NK-007 ameliorates colitis through inhibition of innate immune response. Int. Immunopharmacol. 14, 487-4941
38. Lu, L., Wang, J., Zhang, F., Chai, Y., Brand, D., Wang, X., Horwitz, D. A., Shi, W., Zheng, S. G. (2010) Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. J. Immunol. 184, 4295-43061
39. Horowitz, J. C., Lee, D. Y., Waghray, M., Keshamouni, V. G., Thomas, P. E., Zhang, H., Cui, Z., Thannickal, V. J. (2004) Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor- _1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J. Biol. Chem. 279, 1359-13671
40. Conery, A. R., Cao, Y., Thompson, E. A., Townsend C. M., Jr., Ko, T. C., Luo, K. (2004) Akt interacts directly with Smad3 to regulate the sensitivity to TGF-_ induced apoptosis. Nat. Cell Biol. 6, 366-3721
41. Chen, Z. X., Riggs, A. D. (2011) DNA methylation and demethylation in mammals. J. Biol. Chem. 286, 18347-183531
42. Ooi, S. K., Bestor, T. H. (2008) The colorful history of active DNA demethylation. Cell 133, 1145-11481
43. Lei, J., Hasegawa, H., Matsumoto, T., Yasukawa, M. (2010) Peroxisome proliferator-activated receptor _ and _ agonists together with TGF-_ convert human CD4+CD25-T cells into functional Foxp3+ regulatory T cells. J. Immunol. 185, 7186-71981
44. Kim, Y. C., Kim, K. K., Shevach, E. M. (2010) Simvastatin induces Foxp3+T regulatory cells by modulation of transforming growth factor- _ signal transduction. Immunology 130, 484-4931
45. Deng, C., Lu, Q., Zhang, Z., Rao, T., Attwood, J., Yung, R., Richardson, B. (2003) Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum. 48, 746-7561
46. Lu, Q., Wu, A., Richardson, B. C. (2005) Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J. Immunol. 174, 6212-62191
47. McCoy, K. D., Le Gros, G. (1999) The role of CTLA-4 in the regulation of T cell immune responses. Immunol. Cell Biol. 77, 1-101
48. Keir, M. E., Butte, M. J., Freeman, G. J., Sharpe, A. H. (2008) PD-1 and its ligands in tolerance and immunity. Ann. Rev. Immunol. 26, 677-7041
49. Lin, J., Ziring, D., Desai, S., Kim, S., Wong, M., Korin, Y., Braun, J., Reed, E., Gjertson, D., Singh, R. R. (2008) TNF blockade in human diseases: an overview of efficacy and safety. Clin. Immunol. 126, 13-30.